14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.11 $8.20 Friday, 3rd May 2024 GLUE stock ended at $5.65. This is 0.89% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.63% from a day low at $5.65 to a day high of $5.85.
90 days $4.19 $8.84
52 weeks $2.44 $8.84

Historical Monte Rosa Therapeutics, Inc. prices

Date Open High Low Close Volume
Aug 23, 2023 $6.37 $6.41 $6.30 $6.39 109 843
Aug 22, 2023 $6.32 $6.41 $6.20 $6.34 196 417
Aug 21, 2023 $6.31 $6.51 $6.18 $6.24 204 150
Aug 18, 2023 $6.30 $6.58 $6.30 $6.32 136 263
Aug 17, 2023 $6.45 $6.50 $6.28 $6.38 225 112
Aug 16, 2023 $6.54 $6.63 $6.37 $6.47 514 134
Aug 15, 2023 $6.56 $6.97 $6.40 $6.58 309 885
Aug 14, 2023 $6.63 $6.71 $6.36 $6.53 175 748
Aug 11, 2023 $6.75 $6.81 $6.50 $6.69 466 607
Aug 10, 2023 $6.87 $6.93 $6.58 $6.68 209 908
Aug 09, 2023 $6.83 $7.05 $6.58 $6.79 57 472
Aug 08, 2023 $6.71 $6.89 $6.58 $6.87 53 239
Aug 07, 2023 $6.95 $6.95 $6.62 $6.72 129 411
Aug 04, 2023 $6.72 $7.24 $6.72 $6.88 79 871
Aug 03, 2023 $6.72 $6.85 $6.56 $6.72 32 558
Aug 02, 2023 $6.81 $6.96 $6.56 $6.78 83 496
Aug 01, 2023 $7.07 $7.11 $6.84 $6.90 39 337
Jul 31, 2023 $7.10 $7.33 $6.99 $7.07 93 321
Jul 28, 2023 $6.86 $7.17 $6.81 $7.08 110 381
Jul 27, 2023 $6.95 $7.10 $6.69 $6.76 85 780
Jul 26, 2023 $6.69 $7.06 $6.51 $6.87 63 024
Jul 25, 2023 $7.02 $7.11 $6.59 $6.70 61 038
Jul 24, 2023 $7.01 $7.11 $6.85 $7.05 163 268
Jul 21, 2023 $7.05 $7.24 $6.98 $7.02 76 622
Jul 20, 2023 $6.98 $7.45 $6.87 $6.96 82 188
Click to get the best stock tips daily for free!

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ... GLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT